| 24th Feb 2022 7:00 am |
RNS |
Artificial Intelligence deal with OneThree Biotech |
| 31st Jan 2022 7:00 am |
RNS |
Confirmation of vaccine platform licence execution |
| 17th Jan 2022 7:00 am |
RNS |
Exclusive license of RNA-based immunotherapy asset |
| 16th Dec 2021 7:00 am |
RNS |
Poolbeg to develop oral vaccine delivery platform |
| 6th Dec 2021 7:00 am |
RNS |
Poolbeg signs option for new vaccine candidate |
| 25th Nov 2021 7:00 am |
RNS |
Scientific Advisory Board Appointment |
| 18th Nov 2021 7:00 am |
RNS |
Update on POLB 001 Clinical Development |
| 14th Oct 2021 9:05 am |
RNS |
Second Price Monitoring Extn |
| 14th Oct 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 14th Oct 2021 7:00 am |
RNS |
PredictViral Patent Update |
| 7th Oct 2021 7:00 am |
RNS |
RNA sequencing ahead of AI analysis programme |
| 13th Sep 2021 7:00 am |
RNS |
September and October Investor conferences |
| 7th Sep 2021 7:00 am |
RNS |
POLB001 US Patent Update |
| 23rd Aug 2021 9:06 am |
RNS |
Second Price Monitoring Extn |
| 23rd Aug 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 4th Aug 2021 11:30 am |
RNS |
Holding(s) in Company |
| 23rd Jul 2021 1:26 pm |
RNS |
TR-1 |
| 19th Jul 2021 7:00 am |
RNS |
Admission to AIM |
